v2.4.0.8

STOCKHOLDERS' DEFICIENCY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2013
Stockholders Equity Note [Abstract] |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | The following assumptions were used in estimating the fair value of stock options granted during the years ended December 31, 2013 and 2012:
|  | 2013 |  |  | 2012 |
Weighted Average Exercise Price |  | $ | 0.37 |  |  | $ | 1.62 |
Expected Life |  |  | 2 years |  |  |  | 2-5 years |
Volatility |  |  | 125.0 | % |  |  | 50.0 | %
Dividend Yield |  |  | 0 | % |  |  | 0 | %
Risk-free interest rate |  |  | 0.30% - 1.62 | % |  |  | 0.41 | %
Weighted Average Grant Date Fair Value of Options Issued |  | $ | 0.37 |  |  | $ | 1.70 |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | A summary of the Company’s options outstanding and exercisable is presented below:
|  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  |  | Average |  |  |  |
|  |  |  | Weighted |  | Remaining |  |  |  |
|  |  |  | Average |  | Contractual |  | Aggregate |
|  | Number of |  | Exercise |  | Life |  | Intrinsic |
|  | Shares |  | Price |  | (Years) |  | Value |
Balance – January 1, 2012 |  | - |  | - |  | - |  |  |  |
Granted |  | 2,000,000 |  | 1.62 |  | 5.18 |  |  |  |
Exercised |  | - |  |  |  |  |  |  |  |
Cancelled |  | - |  |  |  |  |  |  |  |
Balance – December 31, 2012 |  | 2,000,000 |  | 1.62 |  | 5.18 |  | $ | — |
Granted |  | 75,000 |  | 0.37 |  | 4.48 |  |  |  |
Exercised |  | - |  |  |  |  |  |  |  |
Cancelled |  | 1,262,500 |  | 1.57 |  | - |  |  |  |
Balance – December 31, 2013 |  | 812,500 |  | 1.58 |  | 3.04 |  | $ | — |
Balance – December 31, 2013 (exercisable) |  | 737,500 |  | 1.70 |  | 2.89 |  | $ | — |
Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block] | The following table summarizes the Company’s warrant activity through December 31, 2013:
|  |  |  |  |  | Weighted |  |  |
|  |  |  |  |  | Average |  |  |
|  |  |  | Weighted |  | Remaining |  |  |
|  |  |  | Average |  | Contractual |  | Aggregate |
|  | Number of |  | Exercise |  | Life |  | Intrinsic |
|  | Shares |  | Price |  | (Years) |  | Value |
Warrants outstanding at January 1, 2012 |  | 2,320,000 |  | $ | 1.00 |  | 2.96 |  |  |  |
Granted |  | 309,900 |  | $ | 1.00 |  | 3.78 |  |  |  |
Warrants outstanding at December 31, 2012 |  | 2,629,900 |  | $ | 1.00 |  | 3.06 |  |  |  |
Granted |  | 7,800,000 |  | $ | 1.00 |  | 4.43 |  |  |  |
Expired |  | — |  |  | — |  | — |  |  |  |
Exercised |  | — |  |  | — |  | — |  |  |  |
Warrants outstanding at December 31, 2013 |  | 10,429,900 |  | $ | 1.00 |  | 4.08 |  | $ | — |
Warrants outstanding at December 31, 2013 (exercisable) |  | 10,429,900 |  | $ | 1.00 |  | 4.08 |  | $ | — |
Series B Preferred Stock [Member] |
Stockholders Equity Note [Abstract] |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | The fair value of these warrants on the issuance date was calculated using a compound option model that includes characteristics of both a binomial lattice and the Black-Scholes formula with the following weighted average assumptions:
Dividend Yield |  |  | 0.00 | %
Volatility |  |  | 95.00 | %
Risk-free Interest Rate |  |  | 0.66-0.72 | %
Expected Lives |  |  | 4.78 years |
Weighted Average Fair Value per Warrant |  |  | 0.25 | %
Warrants Issued |  |  | 309,900 |
Aggregate Grant Date Fair Value |  | $ | 83,673 |

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 28 -Article 5 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration